Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|6|469-477

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.6, 2013-12, pp. : 469-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 385-394

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety of Onco-Retroviral Vectors

By  

Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. : 501-515

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 453-468

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Biosafety of Viral Vectors Commonly Used in Gene Therapy and Vaccination)

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 383-384

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 478-491

Bentham Science Publishers

Access to resources Recommend Favorite